Rhein/Fe3+ nanoassembly for triple-negative breast cancer treatment via a ferroptosis and immunogenic death
Article
Figures
Metrics
Preview PDF
Reference
Related
Cited by
Materials
摘要:
Abstract:
关键词:
Keywords:
Project Supported:
This work was supported by the Scientific and technological innovation project of China Academy of Chinese Medical Sciences (Nos. CI2023E005TS02, CI2023E005TS05, CI2023E005TS08 and CI2023E005TS09), Beijing Nova Program (No. 20240484502). Foundation of Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences (Nos. ZYTS-2025006, ZYTS-2025012). All animal experiments were approved by the Laboratory Animal Ethics Committee of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (Ethics Approval No. 2025B085).
Shuntao Liang a, c,, Licheng Gan a, d,, Xiaomei Tao c, Fei Xia a, b, Qingchao Tu a, Linying Zhong a, Yuanfeng Fu a, Yinan Liu a, Yuqing Meng a, Qiaoli Shi a, Junzhe Zhang a, Jigang Wang a, d,?, Chong Qiu a, b,?. Rhein/Fe3+ nanoassembly for triple-negative breast cancer treatment via a ferroptosis and immunogenic death[J]. Chinese Herbal Medicines (CHM),2026,18(2):481-483
